Intercure Stock (NASDAQ:INCR), Quotes and News Summary

Q: What sector and industry does Intercure (INCR) operate in?

Intercure is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.

Intercure Stock (NASDAQ: INCR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 91.923K
Day Range	- - -
52 Wk Range	0.990 - 2.920
Market Cap	$120.768M
P/E Ratio	21.163
Dividend Yield	-
Exchange	NASDAQ
RSI	62
Short Interest	0.36%
Days to Cover	1

Recent News

This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict

Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany.

Patricio Liddle

Canndoc Reports Record Revenue Amid Cannabis Market Turmoil

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023,

Jelena Martinovic

Medical Cannabis Company Better Is Suing InterCure For $35M

Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure (NASDAQ: INCR) for $35 million.

Vuk Zdinjak

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.7

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Intercure (INCR) stock?

You can purchase shares of Intercure (NASDAQ: INCR) through any online brokerage.

View our list of the best stock brokerages.

Who are Intercure's (INCR) competitors?

There are no as such competitors for Intercure.

What is the target price for Intercure (INCR) stock?

The latest price target for Intercure (NASDAQ: INCR) was reported by TD Cowen on Wednesday, April 12, 2023. The analyst firm set a price target for 5.00 expecting INCR to rise to within 12 months (a possible 88.68% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Intercure (INCR)?

The stock price for Intercure (NASDAQ: INCR) is $2.65 last updated April 18, 2024 at 7:36 PM EDT.

Does Intercure (INCR) pay a dividend?

There are no upcoming dividends for Intercure.

When is Intercure (NASDAQ:INCR) reporting earnings?

Intercure’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Intercure (INCR) going to split?

There is no upcoming split for Intercure.

What sector and industry does Intercure (INCR) operate in?

Intercure is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.